Does SELINEXOR Cause Malignant neoplasm progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Malignant neoplasm progression have been filed in association with SELINEXOR (XPOVIO). This represents 0.3% of all adverse event reports for SELINEXOR.
20
Reports of Malignant neoplasm progression with SELINEXOR
0.3%
of all SELINEXOR reports
12
Deaths
8
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SELINEXOR?
Of the 20 reports, 12 (60.0%) resulted in death, 8 (40.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELINEXOR. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does SELINEXOR Cause?
Nausea (2,372)
Fatigue (1,795)
Decreased appetite (1,290)
Diarrhoea (1,190)
Plasma cell myeloma (1,046)
Vomiting (860)
Asthenia (794)
Death (761)
Thrombocytopenia (692)
Platelet count decreased (610)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SELINEXOR Alternatives Have Lower Malignant neoplasm progression Risk?
SELINEXOR vs SELPERCATINIB
SELINEXOR vs SELUMETINIB
SELINEXOR vs SEMAGLUTIDE
SELINEXOR vs SEMUSTINE
SELINEXOR vs SENNA LEAF